av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

USD

Last Close

39.94

17/05 20:00

Market Cap

2.00B

Beta: 2.11

Volume Today

438.32K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-22K
-
-213.50K
870.45%
-698.50K
227.17%
-1.38M
97.14%
-892K
35.22%
-1.58M
77.24%
-2.09M
32.10%
-1.41M
32.56%
-987K
29.93%
-259.50K
73.71%
-173.50K
33.14%
average payables
1.49M
-
2.42M
62.18%
2.05M
15.21%
1.62M
21.00%
1.73M
6.44%
1.39M
19.42%
1.12M
19.43%
1.11M
0.94%
1.14M
2.43%
2.28M
100.70%
3.42M
49.61%
average receivables
266.50K
-
458K
71.86%
698.50K
52.51%
1.38M
97.14%
1.83M
33.04%
2.52M
37.61%
2.09M
17.16%
1.41M
32.56%
987K
29.93%
259.50K
73.71%
1.49M
473.22%
book value per share
60.13
-
35.51
40.94%
44.84
26.26%
39.21
12.54%
27.58
29.67%
11.88
56.92%
6.48
45.45%
7.06
8.98%
9.78
38.53%
6.96
28.90%
8.86K
127,226.26%
capex per share
-0.79
-
-0.32
59.20%
-0.75
132.84%
-0.41
46.07%
-0.21
48.67%
-0.08
62.68%
-0.05
35.28%
-0.05
3.91%
-0.03
44.36%
-0.04
33.82%
capex to depreciation
-1.43
-
-0.57
60.41%
-1.22
114.33%
-0.67
44.70%
-0.34
49.91%
-0.21
36.48%
-0.15
29.65%
-0.40
162.51%
-0.41
3.06%
-0.63
55.05%
capex to operating cash flow
0.06
-
0.02
69.53%
0.05
159.55%
0.02
50.64%
0.02
26.48%
0.01
39.60%
0.02
45.74%
0.04
143.90%
0.02
46.62%
0.02
14.06%
capex to revenue
-1.03
-
-0.54
47.58%
-0.89
65.41%
-0.41
54.44%
-0.14
65.39%
-0.09
39.25%
-0.20
140.02%
-0.21
2.26%
-0.27
28.35%
-0.78
188.80%
cash per share
56.97
-
33.73
40.79%
44.80
32.82%
28.04
37.42%
16.27
41.97%
9.00
44.65%
4.44
50.71%
6.56
47.80%
9.52
45.18%
6.50
31.70%
8.74K
134,330.96%
days of inventory on hand
days payables outstanding
350.77
-
days sales outstanding
43.42
-
43.46
0.11%
64.61
48.65%
95.96
48.52%
53.85
43.88%
121.00
124.71%
103.69
14.31%
88.67
14.49%
13.50
84.78%
53.74
298.10%
139.36
159.34%
debt to assets
0.01
-
-0.05
577.03%
0.02
-
0.03
39.63%
0.03
2.41%
0.01
50.38%
0.01
53.65%
0.01
67.13%
0.01
52.25%
debt to equity
0.01
-
-0.06
573.73%
0.03
-
0.04
31.33%
0.04
6.61%
0.02
57.25%
0.01
56.39%
0.01
70.49%
0.01
52.09%
dividend yield
earnings yield
-0.04
-
-0.07
71.41%
-0.08
15.49%
-0.36
327.84%
-0.25
28.74%
-4.83
1,793.93%
-1.56
67.74%
-0.12
92.61%
-0.04
63.02%
-0.06
38.03%
-73.60
125,175.76%
enterprise value
1.76B
-
1.61B
8.85%
1.45B
9.47%
316.95M
78.20%
331.36M
4.55%
11.54M
96.52%
24.78M
114.66%
478.94M
1,833.10%
1.62B
238.33%
2.06B
27.40%
-30.35M
101.47%
enterprise value over ebitda
-22.45
-
-13.23
41.07%
-11.11
16.01%
-2.33
79.07%
-3.45
48.39%
-18.18
426.77%
-0.43
97.66%
-12.54
2,844.01%
-23.99
91.29%
-20.27
15.51%
0.21
101.06%
ev to operating cash flow
-26.04
-
-15.82
39.25%
-14.70
7.04%
-2.80
80.93%
-3.32
18.26%
-0.15
95.37%
-0.53
247.94%
-11.85
2,120.69%
-26.60
124.43%
-19.90
25.19%
ev to sales
428.61
-
447.88
4.50%
265.34
40.76%
46.71
82.40%
26.00
44.33%
1.21
95.35%
6.93
473.02%
64.56
831.11%
348.40
439.61%
875.86
151.40%
-4.41
100.50%
free cash flow per share
-13.52
-
-17.36
28.44%
-16.04
7.62%
-17.11
6.67%
-11.87
30.62%
-7.28
38.64%
-3.25
55.38%
-1.42
56.44%
-1.45
2.43%
-2.25
55.27%
free cash flow yield
-0.04
-
-0.06
70.38%
-0.07
7.52%
-0.32
372.47%
-0.28
13.51%
-2.43
771.31%
-1.46
39.97%
-0.08
94.46%
-0.04
53.56%
-0.05
34.61%
graham net net
51.90
-
27.65
46.73%
37.50
35.63%
10.68
71.52%
7.19
32.72%
6.04
15.95%
2.46
59.22%
5.68
130.67%
8.94
57.30%
5.94
33.53%
8.03K
135,112.03%
graham number
144.03
-
125.82
12.64%
140.83
11.93%
129.44
8.09%
82.08
36.59%
62.21
24.20%
22.50
63.83%
17.90
20.44%
19.03
6.29%
20.25
6.40%
24.12K
119,037.24%
income quality
0.83
-
0.86
3.63%
0.78
9.59%
0.88
13.12%
1.07
22.14%
0.50
53.67%
0.91
83.32%
0.68
25.91%
0.86
27.81%
0.92
6.91%
intangibles to total assets
0.09
-
0.13
43.07%
0.09
29.49%
0.46
392.99%
0.50
10.31%
0.32
35.33%
0.42
30.71%
0.14
65.87%
0.07
53.04%
0.09
30.35%
0.06
34.18%
interest coverage
-87.86
-
-7.61
-
-1.04
86.39%
39.61
-
interest debt per share
0.17
-
0.43
149.52%
-2.60
698.11%
2.63
-
14.90
466.68%
0.25
98.31%
0.12
53.41%
0.07
39.58%
0.02
66.22%
52.47
218,769.94%
inventory turnover
invested capital
0.01
-
-0.06
573.73%
0.03
-
0.04
31.33%
0.04
6.61%
0.02
57.25%
0.01
56.39%
0.01
70.49%
0.01
52.09%
market cap
1.93B
-
1.63B
15.53%
1.52B
6.73%
359.41M
76.38%
365.08M
1.58%
31.33M
91.42%
32.35M
3.27%
519.29M
1,505.20%
1.66B
218.99%
2.09B
26.16%
1.92M
99.91%
net current asset value
277.89M
-
168.63M
39.32%
247.46M
46.74%
77.64M
68.62%
65.50M
15.64%
67.33M
2.79%
37.79M
43.87%
171.36M
353.45%
385.66M
125.06%
291.16M
24.50%
395.24M
35.74%
net debt to ebitda
2.16
-
0.21
90.30%
0.52
146.97%
0.31
39.77%
0.35
12.73%
31.16
8,772.35%
0.13
99.58%
1.06
711.33%
0.53
49.42%
0.25
53.35%
0.23
8.47%
net income per share
-15.33
-
-19.81
29.21%
-19.66
0.77%
-18.99
3.41%
-10.86
42.83%
-14.48
33.38%
-3.47
76.02%
-2.02
41.91%
-1.64
18.45%
-2.62
59.21%
-2.92K
111,374.91%
operating cash flow per share
-12.72
-
-17.04
33.90%
-15.28
10.29%
-16.70
9.27%
-11.66
30.18%
-7.21
38.21%
-3.20
55.59%
-1.36
57.39%
-1.42
4.23%
-2.21
55.71%
payables turnover
1.04
-
receivables turnover
8.41
-
8.40
0.10%
5.65
32.73%
3.80
32.67%
6.78
78.19%
3.02
55.50%
3.52
16.70%
4.12
16.94%
27.04
556.88%
6.79
74.88%
2.62
61.44%
research and ddevelopement to revenue
16.40
-
29.11
77.54%
18.28
37.20%
15.14
17.19%
7.55
50.15%
6.97
7.69%
11.94
71.43%
5.73
51.99%
11.46
99.90%
34.90
204.47%
0.04
99.88%
return on tangible assets
-0.26
-
-0.55
111.84%
-0.42
24.23%
-0.62
48.31%
-0.59
3.79%
-1.44
142.64%
-0.71
50.45%
-0.30
58.38%
-0.17
42.60%
-0.38
124.49%
-0.32
15.55%
revenue per share
0.77
-
0.60
22.16%
0.85
40.77%
1.00
18.37%
1.49
48.31%
0.91
38.57%
0.25
73.04%
0.25
1.61%
0.11
56.65%
0.05
53.67%
142.07
282,514.91%
roe
-0.26
-
-0.56
118.77%
-0.44
21.41%
-0.48
10.44%
-0.39
18.72%
-1.22
209.63%
-0.54
56.04%
-0.29
46.70%
-0.17
41.13%
-0.38
123.92%
-0.33
12.45%
roic
-0.25
-
-0.55
118.31%
-0.47
15.46%
-0.47
0.28%
-0.40
14.98%
-1.21
205.13%
-0.54
55.58%
-0.29
46.57%
-0.17
41.91%
-0.38
125.82%
-0.33
13.57%
sales general and administrative to revenue
3.60
-
5.75
59.68%
6.17
7.37%
5.30
14.13%
1.96
62.99%
2.02
2.96%
4.32
113.71%
1.95
54.86%
4.41
126.04%
11.54
161.92%
4.49
61.07%
shareholders equity per share
60.13
-
35.51
40.94%
44.84
26.26%
39.21
12.54%
27.58
29.67%
11.88
56.92%
6.48
45.45%
7.06
8.98%
9.78
38.53%
6.96
28.90%
8.86K
127,226.26%
stock based compensation to revenue
1.11
-
1.91
72.72%
2.33
21.99%
2.26
3.17%
0.97
57.19%
0.85
12.31%
1.27
50.34%
0.53
58.56%
1.92
264.73%
6.62
244.07%
tangible asset value
288.01M
-
179.17M
37.79%
258.92M
44.51%
90.83M
64.92%
77.80M
14.35%
73.44M
5.61%
41.82M
43.05%
175.18M
318.86%
389.21M
122.18%
294.91M
24.23%
401.98M
36.31%
tangible book value per share
54.15
-
28.56
47.26%
38.63
35.28%
-0.02
100.05%
9.08
43,373.55%
7.03
22.53%
2.88
59.01%
5.91
105.01%
9.08
53.62%
6.29
30.72%
8.30K
131,815.06%
working capital
284.84M
-
180.49M
36.63%
264.70M
46.65%
160.35M
39.42%
117.02M
27.02%
86.48M
26.10%
55.05M
36.34%
183.64M
233.55%
394.31M
114.72%
299.08M
24.15%
400.57M
33.93%

All numbers in USD (except ratios and percentages)